Emerald Investment Advisers LLC Takes $7.01 Million Position in The Ensign Group, Inc. $ENSG

Emerald Investment Advisers LLC bought a new stake in shares of The Ensign Group, Inc. (NASDAQ:ENSG) in the 2nd quarter, Holdings Channel.com reports. The firm bought 43,732 shares of the company’s stock, valued at approximately $7,010,000.

Several other institutional investors and hedge funds have also bought and sold shares of ENSG. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in The Ensign Group by 9.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock valued at $20,956,000 after purchasing an additional 14,590 shares during the last quarter. Geneos Wealth Management Inc. grew its holdings in shares of The Ensign Group by 150.3% in the first quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock worth $50,000 after purchasing an additional 230 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of The Ensign Group by 65.9% in the second quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock worth $83,000 after buying an additional 213 shares during the period. Amundi increased its stake in shares of The Ensign Group by 480,216.7% in the second quarter. Amundi now owns 57,638 shares of the company’s stock worth $8,583,000 after buying an additional 57,626 shares during the period. Finally, Brown Advisory Inc. raised its holdings in The Ensign Group by 26.1% during the 2nd quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock valued at $314,000 after buying an additional 421 shares during the last quarter. 96.12% of the stock is currently owned by institutional investors.

The Ensign Group Price Performance

Shares of ENSG stock opened at $179.48 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.21 and a current ratio of 1.21. The Ensign Group, Inc. has a fifty-two week low of $141.58 and a fifty-two week high of $218.00. The firm has a market cap of $10.46 billion, a P/E ratio of 28.13, a P/E/G ratio of 1.73 and a beta of 0.68. The business’s 50 day moving average price is $171.11 and its 200-day moving average price is $184.42.

The Ensign Group (NASDAQ:ENSG) last announced its earnings results on Monday, July 27th. The company reported $1.92 EPS for the quarter, beating analysts’ consensus estimates of $1.80 by $0.12. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%.The company had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter in the prior year, the company earned $1.59 earnings per share. The firm’s revenue for the quarter was up 16.7% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. On average, equities research analysts anticipate that The Ensign Group, Inc. will post 6.93 earnings per share for the current year.

The Ensign Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th were given a dividend of $0.065 per share. This represents a $0.26 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date of this dividend was Tuesday, June 30th. The Ensign Group’s payout ratio is presently 4.08%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Wall Street Zen cut shares of The Ensign Group from a “buy” rating to a “hold” rating in a research report on Saturday, July 25th. Weiss Ratings cut shares of The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, June 16th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $228.00 price objective on shares of The Ensign Group in a research note on Tuesday, July 28th. Finally, Truist Financial increased their target price on shares of The Ensign Group from $202.00 to $207.00 and gave the stock a “hold” rating in a report on Thursday, July 30th. Four equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $216.25.

Insider Buying and Selling at The Ensign Group

In other The Ensign Group news, Director John O. Agwunobi sold 392 shares of the company’s stock in a transaction on Monday, July 20th. The shares were sold at an average price of $171.06, for a total value of $67,055.52. Following the completion of the transaction, the director directly owned 9,503 shares in the company, valued at approximately $1,625,583.18. This represents a 3.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Barry M. Smith sold 700 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $164.28, for a total transaction of $114,996.00. Following the completion of the sale, the director directly owned 21,352 shares of the company’s stock, valued at approximately $3,507,706.56. This represents a 3.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.00% of the stock is currently owned by corporate insiders.

About The Ensign Group

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.